Company: OXBRW
Filing Date: 2025-05-12
Form Type: S-3
Source: 0001641172-25-009665
Chunk: 2

Company: OXBRIDGE RE HOLDINGS Ltd
Filing Date: 2025-05-12
Form: S-3
Chunk 2
---
 securities.

Each time securities are sold using this prospectus, we will provide a supplement to this prospectus and possibly other offering materials containing specific information about the offering and the terms of the securities being sold, including the offering price. The supplement or other offering materials may also add, update or change information contained or incorporated by reference in this prospectus. You should read this prospectus, any prospectus supplement, any other offering materials and the information incorporated by reference carefully before you invest.

We may offer and sell these securities to or through underwriters, dealers or agents, or directly to investors, on a continued or a delayed basis. The supplements to this prospectus will provide the specific terms of the plan of distribution.

Our ordinary shares and warrants are listed on The NASDAQ Capital Market under the symbol “OXBR” and “OXBRW” respectively. On May 5, 2025, the last reported sale price on The NASDAQ Capital Market of our ordinary shares was $1.83 per share and of our warrants was $0.41 per warrant.

The aggregate market value of our outstanding common stock held by non-affiliates pursuant to General Instruction I.B.6 of Form S-3 was approximately $12,413,340, which was calculated based on 7,442,922 shares of common stock outstanding as of May 5, 2025, of which 6,783,246 shares were held by affiliates, and a price of $1.83 per share, which was the closing price of our common stock on the Nasdaq Capital Market on May 5, 2025. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75,000,000. We have not sold any securities pursuant to General Instruction I.B.6 of Form S-3 during the 12 calendar months prior to and including the date of this prospectus.

Investment in our securities involves risks, including those described in the section titled “Risk Factors” on page 15 of this prospectus. Please read carefully and consider these risk factors, as well as those included in the reports we file under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), such as our most recent Annual Report on Form 10-K, and those included in any applicable prospectus supplement and/or